Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndiana will receive $1.1 million in a settlement with Pfizer Inc. over its marketing of the drugs Zyvox and Lyrica.
Indiana Attorney General Greg Zoeller said Wednesday that the $1.1 million is Indiana's share of a $42.9 million settlement Pfizer reached to resolve allegations that the company unlawfully promoted those drugs.
Thirty-two states and the 32 states and the District of Columbia claimed that Pfizer used deceptive practices in marketing Zyvox, an antibacterial agent, and promoted off-label uses for Lyrica, which is used to treat fibromyalgia.
Under the settlement, Pfizer is not admitting wrongdoing but says it will reform how it markets the drugs.
Please enable JavaScript to view this content.